emerging market (EM)

The capacity of rich countries to spend on record fiscal stimulus has long-lasting implications.

Vaccination and immunisation will pave the way for a robust economic recovery.

Chinese equities, which have outperformed the US and European markets year-to-date, remain favoured by UBS Asset Management.

"We believe it is time for caution but not panic,” says Bank of Singapore (BOS) Head of Investment Strategy Eli Lee.

Clearly, what was once unthinkable and unprecedented is now rapidly turning into the norm — with no end in sight.

The region’s gross domestic product will decline by 0.7% in 2020, down from June’s projection of an increase of 0.1%.

A Bloomberg study of 17 emerging markets has found a 42% correlation between gross domestic product per capita and stock performance since the virus-fueled risk sell-off began on Jan 2020.

If this happened along with a change in the US administration, emerging market equities could benefit “if trade policy risks diminish while US tax risks rise”, according to the note.

Chinese equities, which have outperformed the US and European markets year to date, remains favoured by UBS Asset Management, with some showing clear signs that China’s economy is recovering from the Covid–19 lockdowns.

Yoma is now primed to ride on Myanmar's growth